AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of AMPHORA® Contraceptive Vaginal Gel
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Citric acid/lactic acid/potassium bitartrate (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms AMPOWER
- Sponsors Evofem Biosciences
- 16 Feb 2018 Status changed from recruiting to active, no longer recruiting, according to an Evofem media release.
- 23 Jan 2018 According to an Evofem media release, this trial is expected to be fully enrolled in late February of 2018 with data reported in the first quarter of 2019.
- 29 Jul 2017 New trial record